Forward the completed form and other documents being provided to the sponsor. Investigators should not send this form directly to the Food and Drug Administration.
Sponsor: the sponsor will incorporate this information along with other technical data into an Investigational New Drug Application (IND).
Qualifications: provide curriculum vitae or other statement of qualifications as described in Section 2.
Protocol: provide protocol outline as described in Section 8.
Space: provide a separate page if additional space is needed.
Subinvestigators: if not applicable, enter "None".
Signature: a willfully false statement is a criminal offense.
| Question | Answer |
|---|---|
| Form Name | Form FDA 1572 |
| Form Length | 2 pages |
| Fillable? | Yes |
| Fillable fields | 740 |
| Avg. time to fill out | 60+ min |
| Edition | 4/25 |
| Issuing agency | Food and Drug Administration |
| Where to send | The sponsor; investigators should not send this form directly to the Food and Drug Administration |
| Matches the agency's file | Yes, checked October 2, 2026 |
| Other names | Form FDA 1572, FDA 1572, FDA Form 1572, 1572, 1572 form, Statement of Investigator |
| Official source | Form FDA 1572 (Rev 4/25), Food and Drug Administration |
Form Fda 1572 isn’t the one you’re looking for?